SCHEMBL4771528

SCHEMBL4771528

NC(=O)C(CC(=O)Nc1ccc2ccccc2c1)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 4/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP2C9 P11712 4/20 0.45
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.41
ABL1 P00519 2/20 0.41
PDGFRB P09619 2/20 0.41
BCR P11274 2/20 0.41
PDGFRA P16234 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
TP53 P04637 2/20 0.40
TSHR P16473 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766379 0.82 CYP2A6 (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL4766345 0.82 CYP2A6 (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL4771524 0.81 NPC1 (0.47) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL4771519 0.79 CYP2A6 (0.40) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL4776020 0.73 CDK4 (0.49) SMN1; SMN2MEN1KMT2AGAA
SCHEMBL4774839 0.71 DYRK1A (0.51) RAB9ASMN1; SMN2NPC1CYP2C9TP53
SCHEMBL3962124 0.71 CYP2A6 (0.46) RAB9ASMN1; SMN2NPC1ALDH1A1CYP2C9
SCHEMBL4771979 0.70 HDAC1 (0.44) CYP2C9KDM4E
SCHEMBL4771962 0.70 HDAC1 (0.44) CYP2C9KDM4E
SCHEMBL4766014 0.70 ADORA1 (0.47) RAB9ASMN1; SMN2NPC1ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed